| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e8bf07fd57459044d5a8367b18a059c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c166c942f1d8ca215f5034daba935823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30c7a6b38b77453fb467d70d84cbe2e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd80c6be9a4eb5047ae41ef8689e0256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73b24b771941efe4ddcf6a6d48da7444 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1c333e372af936123a9f76264e4f49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20225e3057a169d25ae2aeffe2d08a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db5cd22f38f0d85e656faf1ac57745ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f1f3ea5b97739f2d355f49711696120
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caa9550a198646147bd1a9464a568103 |
| publicationDate |
2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013101987-A1 |
| titleOfInvention |
Detection of feline Immunodeficiency Virus |
| abstract |
Method, device and kit for the detection of antibodies directed to Feline Immunodeficiency Virus (FIV). The method includes contacting the felid biological sample with FIV env polypeptide and detecting whether the polypeptide substantially binds to the antibody in the biological sample. The method will detect FIV antibodies in a sample from animals that have been naturally infected but the method will not detect antibodies in a sample from animals that have not been infected and that have not been vaccinated with an FIV vaccine after within about the previous five to eight weeks. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10156569-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016028733-A1 |
| priorityDate |
2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |